The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy-Reference-Cited by-同舟云学术

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Published:2017-08-10 Issue:8 Volume:12 Page:e0182710
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nagaoki Yuko,Imamura Michio,Aikata Hiroshi,Daijo Kana,Teraoka Yuji,Honda Fumi,Nakamura Yuki,Hatooka Masahiro,Morio Reona,Morio Kei,Kan Hiromi,Fujino Hatsue,Kobayashi Tomoki,Masaki Keiichi,Ono Atsushi,Nakahara Takashi,Kawaoka Tomokazu,Tsuge Masataka,Hiramatsu Akira,Kawakami Yoshiiku,Hayes C. Nelson,Miki Daiki,Ochi Hidenori,Chayama Kazuaki

Funder

Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;K Kiyosawa;Hepatology,1990

2. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;C Niederau;Hepatology,1998

3. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis;K Ikeda;Hepatology,1993

4. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients;G Fattovich;Gastroenterology,1997

5. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C;A Kasahara;Hepatology,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies;Scientific Reports;2023-03-01

3. Factors for the recurrence of hepatocellular carcinoma after hepatic resection;Journal of Gastroenterology;2023-02-01

4. No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy;Global Health & Medicine;2022-08-31

5. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study;World Journal of Gastroenterology;2022-08-14